The Use of Selenium to Treat Secondary Lymphedema - Breast Cancer
Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study to assess the effectiveness of selenium compared to
placebo in reducing the lymphedema in-patients with breast cancer. Secondary objectives are
to assess the impact of selenium on patient's quality of life and to assess the incidence of
adverse effects of selenium therapy.